Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
May 19 2023 - 4:01PM
Business Wire
Exicure, Inc. (“Exicure” or the “Company”) (Nasdaq: XCUR),
announced today it received a notice of non-compliance from Nasdaq
Stock Market LLC (“Nasdaq”) on May 17, 2023 notifying the Company
that, as a result of the Company’s failure to timely file its
Quarterly Report on Form 10-Q for the quarterly period ended March
31, 2023 (the “Form 10-Q”), the Company is not in compliance with
Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires listed
companies to timely file all periodic financial reports with the
U.S. Securities and Exchange Commission (the “SEC”).
Under Nasdaq’s listing rules, Exicure has 60 calendar days to
submit a plan to regain compliance. If the plan is accepted by
Nasdaq, the Company can be granted up to 180 calendar days from the
Form 10-Q due date, or until November 13, 2023, to regain
compliance.
The Company is working diligently to complete its Form 10-Q and
intends to file the Form 10-Q as soon as practicable to regain
compliance with the Rule.
About Exicure
Exicure, Inc. has historically been an early-stage biotechnology
company focused on developing nucleic acid therapies targeting
ribonucleic acid against validated targets. Following its recent
restructuring and suspension of clinical and development
activities, the Company is exploring strategic alternatives to
maximize stockholder value, both with respect to its historical
biotechnology assets and more broadly. For further information, see
www.exicuretx.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. All statements in this press release other than statements of
historical fact may be deemed forward looking including, but not
limited to, statements regarding: the Company’s current business
plans and objectives, including the pursuit of strategic
alternatives to maximize stockholder value. Words such as “plans,”
“expects,” “will,” “anticipates,” “continue,” “advance,”
“believes,” “target,” “may,” “intend,” “could,” and other words and
terms of similar meaning and expression are intended to identify
forward-looking statements, although not all forward-looking
statements contain such terms. Forward-looking statements are based
on management’s current beliefs and assumptions that are subject to
risks and uncertainties and are not guarantees of future
performance. For a discussion of other risks and uncertainties, and
other important factors, any of which could cause the Company’s
actual results to differ from those contained in the
forward-looking statements, see the section titled “Risk Factors”
in the Company’s Annual Report on Form 10-K for the year ended
December 31, 2022 filed with the Securities and Exchange Commission
on March 27, 2023, as updated by the Company’s subsequent filings
with the Securities and Exchange Commission. All information in
this press release is as of the date of the release, and the
Company undertakes no duty to update this information or to
publicly announce the results of any revisions to any of such
statements to reflect future events or developments, except as
required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230519005369/en/
Media: Karen Sharma MacDougall 781-235-3060
ksharma@macdougall.bio
Exicure (NASDAQ:XCUR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Exicure (NASDAQ:XCUR)
Historical Stock Chart
From Jul 2023 to Jul 2024